CDSCO brings in guidelines and SOPs on compounding of offences: Gireesh Babu, New Delhi Tuesday, January 6, 2026, 08:00 Hrs ...

The Drugs Controller General of India (DCGI) has directed manufacturers to follow a procedure for regularisation of 31 Fixed Dose Combinations (FDCs) declared as rational out of the 294 FDCs as per ...

Dr. Reddy’s Laboratories Ltd on Tuesday announced the launch of Hevaxin®, a novel recombinant vaccine for the prevention of Hepatitis E virus (HEV) infection in India, marking a significant milestone ...

(MENAFN- Live Mint) New Delhi: The Drugs Controller General of India (DCGI) has directed the cosmetics industry to follow regulatory protocols, and warned against making“unusual claims” to ...

Zydus Cadila said the drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad. (Representational image) Biophore India Pharmaceuticals on Friday said it has ...

Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on ...

Dr. Reddy’s launches Hevaxin, India’s first approved vaccine for preventing Hepatitis E virus infection in adults aged 18 to ...

The Drug Controller General of India (DCGI) has instructed drug regulators in all states and Union territories to withdraw AstraZeneca's anti-cancer drug Olaparib tablets for patients who have ...

Ahmedabad: A team from the regional office of the Drugs Controller General of India (DCGI) made its first visit to VS Hospital on Monday and initiated a probe into allegations of illegal clinical ...

The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to Serum Institute of India (SII) to manufacture indigenously-developed India's first Quadrivalent Human ...

The DCGI highlighted that the WHO had issued a safety alert identifying multiple counterfeit versions of Adcetris injection 50 mg These fake products are predominantly found at the patient level and ...

New Delhi: The Drugs Controller General of India (DCGI) has directed the cosmetics industry to follow regulatory protocols, and warned against making “unusual claims” to younger-looking skin that ...